22 September 2017
Sign up for Norgine alerts
“Our strategy is to achieve double digit growth by being the ‘go to’ European specialist pharma company partner of choice. We are committed to the development of innovative products and are seeking to acquire late stage assets.
Our three key strategic priorities are: to achieve double digit growth, to strengthen our late stage pipeline and to be a dynamic place to work.”